Brioschi, M.; Gianazza, E.; Andreini, D.; Mushtaq, S.; Cavallotti, L.; Veglia, F.; Tedesco, C.C.; Colombo, G.I.; Pepi, M.; Polvani, G.;
et al. Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting. Antioxidants 2022, 11, 702.
https://doi.org/10.3390/antiox11040702
AMA Style
Brioschi M, Gianazza E, Andreini D, Mushtaq S, Cavallotti L, Veglia F, Tedesco CC, Colombo GI, Pepi M, Polvani G,
et al. Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting. Antioxidants. 2022; 11(4):702.
https://doi.org/10.3390/antiox11040702
Chicago/Turabian Style
Brioschi, Maura, Erica Gianazza, Daniele Andreini, Saima Mushtaq, Laura Cavallotti, Fabrizio Veglia, Calogero C. Tedesco, Gualtiero I. Colombo, Mauro Pepi, Gianluca Polvani,
and et al. 2022. "Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting" Antioxidants 11, no. 4: 702.
https://doi.org/10.3390/antiox11040702
APA Style
Brioschi, M., Gianazza, E., Andreini, D., Mushtaq, S., Cavallotti, L., Veglia, F., Tedesco, C. C., Colombo, G. I., Pepi, M., Polvani, G., Tremoli, E., Parolari, A., & Banfi, C.
(2022). Mercaptoalbumin Is Associated with Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting. Antioxidants, 11(4), 702.
https://doi.org/10.3390/antiox11040702